West Virginia University Cancer Institute is West Virginia’s premier cancer facility with a national reputation of excellence in cancer treatment, prevention and research. The Scientific Programs within the MBRCC are organized to nurture interactions between basic, clinical and population scientists and are designed to impact on specific health disparities and populations with unique needs within our state.Read More
MORGANTOWN, W.Va. – Lori Hazlehurst, Ph.D., Professor (WVU School of Pharmacy - Pharmaceutical Sciences and Co-Leader of the WVU Cancer Institute Research Program the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, has been named as the Associate Director for Basic Research at the WVU Cancer Institute. In this role, she will work closely with Dr. Richard Goldberg, Institute Director, and the leadership team of the WVU Cancer Institute to implement strategic goals to increase the impact of basic and translational cancer research at WVU. The primary strategy is to increase the number of NIH funded investigators focused on cancer research at WVU
The training will highlight the importance of compliance with U.S. export laws and regulations, HSC faculty and staff’s personal responsibilities, and the processes designed to assist them. In particular, the information will look at how export regulations intersect with research, travel abroad, and the ways the Export Control office works with the Office of Global Affairs in the visa process for J-1 scholars and H-1B employees working in each school at HSC.
InovitroTM TTFields Lab Bench System from Novocure recently released several new funding opportunities.